Hyundai Cancer Institute :: Meet the Histiocytosis Treatment Program Team
The Histiocytosis Treatment Program at the Cancer Institute is a multidisciplinary team of nationally recognized medical experts who treat pediatric patients with hystiocytosis.
The Histiocytosis Treatment Program is led by Elyssa Rubin, M.D. and Lilibeth Torno, M.D. Dr. Rubin is board-certified in pediatrics and pediatric hematology/oncology. She completed her fellowship in pediatric hematology/oncology at Children’s Hospital of Orange County and did her pediatric internship and residency training at Kaiser Permanente Los Angeles Medical Center. Dr. Rubin attended medical school at the Sackler School of Medicine, NY State/American Branch in Tel Aviv, Israel.
Dr. Lilibeth Torno is board-certified in pediatrics and pediatric hematology and oncology. Dr. Torno completed her fellowship training at Children’s Hospital of Los Angeles. She completed her residency at CHOC. She attended medical school at University of Santo Tomas, Manila, Philippines. Dr. Torno also speaks Filipino.
Together, Dr. Rubin and Dr. Torno have presented internationally on histiocytosis and treat a significant number of the region’s histiocytosis patients.
|Associate Spotlight: Jenee Areeckal-Social Worker
Dealing with cancer is tough for patients and their families. While going through treatment, social workers help patients and their families through the darkest moments by showing them how strong they can be. Jenee Areeckal is one such social worker. Working with the Cancer Institute’s bone and soft tissue sarcoma, solid tumor, and histiocytosis patients, she is committed to providing patients and their caregivers the support they need during their most vulnerable times.
Read more about Jenee...